{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:46:58Z","timestamp":1783529218114,"version":"3.55.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s40620-019-00698-9","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T08:02:48Z","timestamp":1579766568000},"page":"757-762","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis"],"prefix":"10.1093","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1266-9441","authenticated-orcid":false,"given":"Savino","family":"Sciascia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Radin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Fenoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"De Marchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Besso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Baldovino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Miraglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rubini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Roccatello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,1,23]]},"reference":[{"key":"698_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295\u2013306. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.01753.x","journal-title":"J Thromb Haemost"},{"key":"698_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","volume":"7","author":"PL Meroni","year":"2011","unstructured":"Meroni PL, Borghi MO, Raschi E, Tedesco F (2011) Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol 7:330\u2013339. https:\/\/doi.org\/10.1038\/nrrheum.2011.52","journal-title":"Nat Rev Rheumatol"},{"key":"698_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1023\/A:1025321617304","volume":"23","author":"Y Shoenfeld","year":"2003","unstructured":"Shoenfeld Y, Krause I, Kvapil F et al (2003) Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndrome. J Clin Immunol 23:377\u2013383","journal-title":"J Clin Immunol"},{"key":"698_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11926-013-0402-7","volume":"16","author":"CB Chighizola","year":"2014","unstructured":"Chighizola CB, Gerosa M, Meroni PL (2014) New tests to detect antiphospholipid antibodies: Anti-domain i beta-2-glycoprotein-I antibodies. Curr Rheumatol Rep 16:1\u20139. https:\/\/doi.org\/10.1007\/s11926-013-0402-7","journal-title":"Curr Rheumatol Rep"},{"key":"698_CR5","doi-asserted-by":"publisher","first-page":"15542","DOI":"10.1073\/pnas.95.26.15542","volume":"95","author":"GM Iverson","year":"1998","unstructured":"Iverson GM, Victoria EJ, Marquis DM (1998) Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI. Proc Natl Acad Sci USA 95:15542\u201315546","journal-title":"Proc Natl Acad Sci USA"},{"key":"698_CR6","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1055\/s-0037-1616091","volume":"86","author":"PA McNeeley","year":"2001","unstructured":"McNeeley PA, Dlott JS, Furie RA et al (2001) \u03b22-glycoprotein I-dependent anticardiolipin antibodies preferentially bind the amino terminal domain of \u03b22-glycoprotein I. Thromb Haemost 86:590\u2013595. https:\/\/doi.org\/10.1055\/s-0037-1616091","journal-title":"Thromb Haemost"},{"key":"698_CR7","doi-asserted-by":"publisher","first-page":"7097","DOI":"10.4049\/jimmunol.169.12.7097","volume":"169","author":"GM Iverson","year":"2002","unstructured":"Iverson GM, Reddel S, Victoria EJ et al (2002) Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies. J Immunol 169:7097\u20137103","journal-title":"J Immunol"},{"key":"698_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/art.22306","volume":"56","author":"Y Ioannou","year":"2007","unstructured":"Ioannou Y, Pericleous C, Giles I et al (2007) Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43. Arthritis Rheum 56:280\u2013290. https:\/\/doi.org\/10.1002\/art.22306","journal-title":"Arthritis Rheum"},{"key":"698_CR9","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1002\/art.30633","volume":"63","author":"B De Laat","year":"2011","unstructured":"De Laat B, Van Berkel M, Urbanus RT et al (2011) Immune responses against domain I of \u00df2-glycoprotein I are driven by conformational changes: domain I of \u00df2-glycoprotein I harbors a cryptic immunogenic epitope. Arthritis Rheum 63:3960\u20133968. https:\/\/doi.org\/10.1002\/art.30633","journal-title":"Arthritis Rheum"},{"key":"698_CR10","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1182\/blood-2011-03-340232","volume":"118","author":"V Pengo","year":"2011","unstructured":"Pengo V, Ruffatti A, Legnani C et al (2011) Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. Blood 118:4714\u20134718. https:\/\/doi.org\/10.1182\/blood-2011-03-340232","journal-title":"Blood"},{"key":"698_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jaut.2018.02.002","volume":"90","author":"CB Chighizola","year":"2018","unstructured":"Chighizola CB, Pregnolato F, Andreoli L et al (2018) Beyond thrombosis: Anti-\u03b22GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome. J Autoimmun 90:76\u201383. https:\/\/doi.org\/10.1016\/j.jaut.2018.02.002","journal-title":"J Autoimmun"},{"key":"698_CR12","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1002\/art.39187","volume":"67","author":"L Andreoli","year":"2015","unstructured":"Andreoli L, Chighizola CB, Nalli C et al (2015) Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against antiBeta2-glycoprotein i domain 1 and domain 4\/5: Ratio of anti-domain 1 to anti-domain 4\/5 as a useful new biomarker for antiphospholipid syndrome. Arthritis Rheumatol 67:2196\u20132204. https:\/\/doi.org\/10.1002\/art.39187","journal-title":"Arthritis Rheumatol"},{"key":"698_CR13","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1002\/acr.21904","volume":"65","author":"L Andreoli","year":"2013","unstructured":"Andreoli L, Nalli C, Borghi MO, Pregnolato F, Grossi C, Zangola A, Allegri F, Gerosa M, Mahler M, Norman G, Meroni P, and Tincani A (2013) Domain 1 is the main specificity of anti-b2glycoprotein I antibodies in systemic autoimmune diseases. Arthritis Rheum 65:S4","journal-title":"Arthritis Rheum"},{"key":"698_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.124","author":"S Sciascia","year":"2017","unstructured":"Sciascia S, Amigo M-C, Roccatello D, Khamashta M (2017) Diagnosing antiphospholipid syndrome: \u201cextra-criteria\u201d manifestations and technical advances. Nat Rev Rheumatol. https:\/\/doi.org\/10.1038\/nrrheum.2017.124","journal-title":"Nat Rev Rheumatol"},{"key":"698_CR15","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ekir.2017.04.008","volume":"2","author":"N Pattanashetti","year":"2017","unstructured":"Pattanashetti N, Anakutti H, Ramachandran R et al (2017) Effect of thrombotic microangiopathy on clinical outcomes in Indian patients with lupus nephritis. Kidney Int Rep 2:844\u2013849. https:\/\/doi.org\/10.1016\/j.ekir.2017.04.008","journal-title":"Kidney Int Rep"},{"key":"698_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214559","author":"S Sciascia","year":"2018","unstructured":"Sciascia S, Yazdany J, Dall\u2019Era M et al (2018) Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicentre cohort study. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214559","journal-title":"Ann Rheum Dis"},{"key":"698_CR17","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271\u20131277","journal-title":"Arthritis Rheum"},{"key":"698_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","volume":"15","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D\u2019Agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241\u2013250. https:\/\/doi.org\/10.1097\/01.ASN.0000108969.21691.5D","journal-title":"J Am Soc Nephrol"},{"key":"698_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2014.38","author":"S Sciascia","year":"2014","unstructured":"Sciascia S, Cuadrado MJ, Khamashta M, Roccatello D (2014) Renal involvement in antiphospholipid syndrome. Nat Rev Nephrol. https:\/\/doi.org\/10.1038\/nrneph.2014.38","journal-title":"Nat Rev Nephrol"},{"key":"698_CR20","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","volume":"7","author":"V Pengo","year":"2009","unstructured":"Pengo V, Tripodi A, Reber G et al (2009) Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 7:1737\u20131740. https:\/\/doi.org\/10.1111\/j.1538-7836.2009.03555.x","journal-title":"J Thromb Haemost"},{"key":"698_CR21","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/jth.12865","volume":"13","author":"V Pengo","year":"2015","unstructured":"Pengo V, Ruffatti A, Tonello M et al (2015) Antiphospholipid syndrome: antibodies to domain 1 of \u03b22-glycoprotein 1 correctly classify patients at risk. J Thromb Haemost 13:782\u2013787. https:\/\/doi.org\/10.1111\/jth.12865","journal-title":"J Thromb Haemost"},{"key":"698_CR22","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/rheumatology\/kes388","volume":"52","author":"S Sciascia","year":"2013","unstructured":"Sciascia S, Sanna G, Murru V et al (2013) GAPSS: the global anti-phospholipid syndrome score. Rheumatology (Oxford) 52:1397\u20131403. https:\/\/doi.org\/10.1093\/rheumatology\/kes388","journal-title":"Rheumatology (Oxford)"},{"key":"698_CR23","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1603936","author":"M Radin","year":"2017","unstructured":"Radin M, Cecchi I, Roccatello D et al (2017) Prevalence and thrombotic risk assessment of anti-\u03b22 glycoprotein I domain I antibodies: a systematic review. Semin Thromb Hemost. https:\/\/doi.org\/10.1055\/s-0037-1603936","journal-title":"Semin Thromb Hemost"},{"key":"698_CR24","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1186\/ar4142","volume":"15","author":"D Song","year":"2013","unstructured":"Song D, Wu L, Wang F et al (2013) The spectrum of renal thrombotic microangiopathy in lupus nephritis. Arthritis Res Ther 15:R12. https:\/\/doi.org\/10.1186\/ar4142","journal-title":"Arthritis Res Ther"},{"key":"698_CR25","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1177\/0961203316641772","volume":"25","author":"PL Meroni","year":"2016","unstructured":"Meroni PL (2016) Anti-beta-2 glycoprotein I epitope specificity: from experimental models to diagnostic tools. Lupus 25:905\u2013910. https:\/\/doi.org\/10.1177\/0961203316641772","journal-title":"Lupus"},{"key":"698_CR26","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.1182\/blood-2011-01-333617","volume":"118","author":"C Agostinis","year":"2011","unstructured":"Agostinis C, Biffi S, Garrovo C et al (2011) In vivo distribution of \u03b22 glycoprotein I under various pathophysiologic conditions. Blood 118:4231\u20134238. https:\/\/doi.org\/10.1182\/blood-2011-01-333617","journal-title":"Blood"},{"key":"698_CR27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1182\/blood-2015-09-672139","volume":"127","author":"PL Meroni","year":"2016","unstructured":"Meroni PL, Macor P, Durigutto P et al (2016) Complement activation in antiphospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery. Blood 127:365\u2013367. https:\/\/doi.org\/10.1182\/blood-2015-09-672139","journal-title":"Blood"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-019-00698-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-019-00698-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-019-00698-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:38Z","timestamp":1777564598000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/33\/4\/757\/8328501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,23]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["698"],"URL":"https:\/\/doi.org\/10.1007\/s40620-019-00698-9","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,23]]},"assertion":[{"value":"3 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted according to the declaration of Helsinki and informed consent was given to all patients that participated in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals and informed consent"}}]}}